/Labcorp%20Holdings%20Inc_%20logo%20on%20laptop-by%20monticello%20via%20Shutterstock.jpg)
Labcorp Holdings Inc. (LH), headquartered in Burlington, North Carolina, provides laboratory services. Valued at $19.3 billion by market cap, the company specializes in providing clinical lab tests for allergies, genetics and genomics, colorectal cancer, diabetes, chronic kidney disease, and pregnancy, as well as clinical trials for oncology and COVID-19. The global leader of innovative and comprehensive laboratory services is expected to announce its fiscal first-quarter earnings for 2025 before the market opens on Tuesday, Apr. 29.
Ahead of the event, analysts expect LH to report a profit of $3.75 per share on a diluted basis, up 1.9% from $3.68 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.